Skip to content

Effects of Physical Training on Health Markers of Post-bariatric Patients

Effects of Physical Training on Physical and Functional Fitness, Physical Activity Level, Endothelial Function, Hemodynamic Variables, Bone Metabolism and Quality of Life of Post-bariatric Patients: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04193397
Acronym
Obesity
Enrollment
100
Registered
2019-12-10
Start date
2022-12-01
Completion date
2024-03-31
Last updated
2024-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery

Keywords

Obesity, Muscle mass, Muscle strength, Bone mineral density, Bone microarchitecture

Brief summary

The purpose of this clinical trial is to study the effects of resistance training program on physical-functional fitness, muscle mass and strength, endothelial function, blood pressure, biochemical markers of cardiovascular risk and bone metabolism, density and microstructure and quality of life of post-bariatric patients (Study 1). To compare the bone and muscle changes in post-bariatric patients by Roux-en-Y Gastric Bypass Surgery with non-bariatric controls, as well as to correlate these health indicators with surgery time and weight loss (Study 2).

Detailed description

Randomized controlled trial (Study 1) will feature post-bariatric patients in outpatient care at the public health unit. The post-bariatric patients will be randomized through a random code generator software (www.randomization.com) at a ratio of 1:1, into two groups: a) Intervention group - that will perform a supervised RT program for 6-months or b) Non-exercised control group - that will receive the standard clinical follow-up and shall not change their physical activity behavior. The exercise sessions will include: a) 10-min specific warm-up, consisting of one set of 20 repetitions with loads corresponding to 50% of the resistance used in the first exercise of the training session; b) 45-min of resistance exercises for the upper and lower body (8 single and multi-joint exercises with free weights and machines, including seated rowing, leg press, bench press, leg flexion, pull down, leg extension, shoulder press, and abdominal exercises), performed with 2-3 sets of 8 to 12 repetitions with loads ≥ 70% of one-repetition maximum (1RM) interspersed with 2 min intervals between sets; c) 5-min recovery with stretch and cool-down exercises. During six months, all training sessions will occur three times a week on nonconsecutive days. The outcomes will be assessed by dual energy X-ray emission densitometry (DXA); high resolution peripheral quantitative computed tomography (HR-pQCT), repetition maximum, handgrip strength; biochemical analysis (blood lipid profile, blood glucose and biomarkers of bone formation and absorption and calcium metabolism); venous occlusion plethysmography and nailfold videocapillaroscopy; blood pressure measurement and 36-Item Short-form Health Survey. The cross-sectional study (Study 2) will have 2 groups: post-bariatric patients group (BG) and control group (CG) - non-bariatric controls. Outcomes will be assessed by DXA; HR-pQCT; handgrip strength and biochemical analysis (blood lipid profile, blood glucose and biomarkers of bone formation and absorption and calcium metabolism).

Interventions

BEHAVIORALExercise training

Resistance training program performed during 6 months, 3 sessions per week

Sponsors

Rio de Janeiro State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Intervention group will perform a supervised resistance training program, while non-exercised control group will receive the standard clinical follow-up and shall not change their physical activity behavior (Study 1) and Post-bariatric group or non-bariatric control group (Study 2)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients subjected to Roux-en-Y gastric bypass * Aging 18 to 50-years * At least 12 months from surgery

Exclusion criteria

* Smoking * Alcoholism * Gestation * Cardiovascular disease * Respiratory disease * Neurological disease * Infectious disease * Endocrine disease * Musculoskeletal impairments * Use of hormonal replacement therapy that influence bone metabolism * Use of medications that influence bone metabolism * Start some physical exercise program during the study * Excess weight loss \<50% * Use drugs that interfere with weight * Revisional bariatric surgery * Regular physical exercise

Design outcomes

Primary

MeasureTime frameDescription
Changes from baseline body composition at 6 monthsBaseline and 6 months of follow-upMuscle mass and body mineral density will be assessed by Dual-energy X-ray Absortiometry
Changes from baseline bone microarchitecture at 6 monthsBaseline and 6 months of follow-upBone microarchitecture will be assessed by High-resolution peripheral quantitative computed tomography
Changes from baseline muscle strength at 6 monthsBaseline and 6 months of follow-upMuscle strength will be evaluated by one repetition maximum test and handgrip strength
Changes from baseline blood biomarkers at 6 monthsBaseline and 6 months of follow-upBone formation and reabsorption biomarkers will be evaluated by blood sample collection

Secondary

MeasureTime frameDescription
Changes from baseline quality of life indicators at 6 monthsBaseline and 6 months of follow-upQuality of life indicators will be evaluated by 36-Item Short-form Health Survey
Changes from baseline endothelial function at 6 monthsBaseline and 6 months of follow-upEndothelial function will be evaluated by venous occlusion plethysmography and periungual videocapilaroscopy
Changes from baseline cardiovascular risk factors at 6 monthsBaseline and 6 months of follow-upCardiovascular risk factors will be evaluated by body mass index, waist circumference, blood pressure, triglycerides, HDL-c, LDL-c, total cholesterol, and fasting glycemia
Changes from baseline anthropometric markers at 6 monthsBaseline and 6 months of follow-upAnthropometric markers will be determined by a digital scale and wall-mounted stadiometer
Changes from baseline hemodynamic measurement at 6 monthsBaseline and 6 months of follow-upBlood pressure and heart rate will be assessed by a digital sphygmomanometer

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026